Quantitative vitro drug potency drug susceptibility evaluation Leishmania ssp patients unresponsive antimony therapy Quantitative vitro drug sensitivity Leishmania isolates patients pentavalent antimony SbV therapy radiorespirometric microtechnique RAM isolates histories RAM tests patient history difference RAM drug sensitivity clinical correlation isolates known clinical history clinical history Test sensitivity sensitivity Leishmania SbV micrograms/ml Sb serum drug level isolate patient untreated self-healing cutaneous disease drug resistant RAM parasite drug sensitivity patient physiologic immunologic variables clinical data Potency maximum Sb weight Sb drug lots Glucantime Pentostam Potency changes drug lots explainable Sb content test-to-test variability rapid method drug sensitivity patient isolates activity pentavalent antimonials candidate anti-leishmanials initiation therapy 